NasdaqCM - Delayed Quote USD
Kezar Life Sciences, Inc. (KZR)
4.0700
+0.0100
+(0.25%)
At close: May 16 at 4:00:02 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
7,000
0
0
Operating Expense
89,135
89,135
112,237
71,162
54,659
Operating Income
-89,135
-89,135
-105,237
-71,162
-54,659
Net Non Operating Interest Income Expense
6,869
6,869
9,554
2,923
29
Other Income Expense
-1,470
-1,470
-6,187
--
--
Pretax Income
-83,736
-83,736
-101,870
-68,239
-54,630
Net Income Common Stockholders
-83,736
-83,736
-101,870
-68,239
-54,630
Diluted NI Available to Com Stockholders
-83,736
-83,736
-101,870
-68,239
-54,630
Basic EPS
-13.12
-11.00
-14.04
-10.13
-10.40
Diluted EPS
-13.12
-11.00
-14.04
-10.13
-10.40
Basic Average Shares
7,283.6980
7,290.2450
7,255.3650
6,736.8940
5,275.9330
Diluted Average Shares
7,283.6980
7,290.2450
7,255.3650
6,736.8940
5,275.9330
Total Operating Income as Reported
-90,605
-90,605
-111,424
-71,162
-54,659
Total Expenses
89,135
89,135
112,237
71,162
54,659
Net Income from Continuing & Discontinued Operation
-83,736
-83,736
-101,870
-68,239
-54,630
Normalized Income
-82,266
-82,266
-95,683
-68,239
-54,630
Interest Income
8,462
8,462
11,104
4,108
188
Interest Expense
1,593
1,593
1,550
1,185
159
Net Interest Income
6,869
6,869
9,554
2,923
29
EBIT
-82,143
-82,143
-100,320
-67,054
-54,471
EBITDA
-81,103
-81,103
-99,254
-66,031
-52,961
Reconciled Depreciation
1,040
1,040
1,066
1,023
1,510
Net Income from Continuing Operation Net Minority Interest
-83,736
-83,736
-101,870
-68,239
-54,630
Total Unusual Items Excluding Goodwill
-1,470
-1,470
-6,187
0
0
Total Unusual Items
-1,470
-1,470
-6,187
0
0
Normalized EBITDA
-79,633
-79,633
-93,067
-66,031
-52,961
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/21/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
1.9700
+0.51%
PMVP PMV Pharmaceuticals, Inc.
0.8659
+3.32%
PRTC.L PureTech Health plc
127.00
-2.91%
IPSC Century Therapeutics, Inc.
0.5600
+8.23%
RPTX Repare Therapeutics Inc.
1.3400
+0.75%
BOLT Bolt Biotherapeutics, Inc.
0.2930
-7.57%
ANTX AN2 Therapeutics, Inc.
1.2100
-1.63%
IKNA Ikena Oncology, Inc.
1.1100
+0.91%
SEER Seer, Inc.
2.0700
-0.48%
ASMB Assembly Biosciences, Inc.
13.42
+7.36%